Comprehensive Functional Annotation of Seventy-One Breast Cancer Risk Loci

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Rhie, Suhn Kyong ^a,b   Coetzee, Simon G ^a,b,c   Noushmehr, Houtan ^a,b,c   Yan, Chunli ^a,b   Kim, Jae Mun ^a   Haiman, Christopher A ^a,b   Coetzee, Gerhard A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ALLELE; ANKLE1 GENE; ARTICLE; BREAST CANCER; CANCER RISK; CHROMATIN; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENHANCER REGION; EXON; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE;

ALLELES; BREAST NEOPLASMS; CELLS, CULTURED; CHROMATIN; ENDONUCLEASES; EPIGENESIS, GENETIC; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RESPONSE ELEMENTS; RISK; RISK FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE;

EID: 84878092919     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063925     Document Type: Article

References (95)

1. Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M, (2010) Genetic susceptibility to breast cancer. Molecular oncology 4: 174-191.
2. Peng S, Lu B, Ruan W, Zhu Y, Sheng H, et al. (2011) Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast cancer research and treatment 127: 309-324.
3. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, et al. (2009) Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nature genetics 41: 585-590.
4. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, et al. (2010) A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature genetics 42: 885-892.
5. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093.
6. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, et al. (2011) Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. Journal of the National Cancer Institute 103: 425-435.
7. Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, et al. (2013) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature genetics 44: 312-318.
8. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, et al. (2011) A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nature genetics 43: 1210-1214.
9. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nature genetics 39: 870-874.
10. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nature genetics 39: 631-637.
11. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, et al. (2008) Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nature genetics 40: 703-706.
12. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, et al. (2012) 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer research 72: 1795-1803.
13. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nature genetics 42: 504-507.
14. Zheng W, Long J, Gao YT, Li C, Zheng Y, et al. (2009) Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nature genetics 41: 324-328.
15. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, et al. (2013) Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature genetics 45: 353-361.
16. Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, et al. (2013) Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature genetics 45: 392-398.
17. Gibson G, (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13: 135-145.
18. Ecker JR, Bickmore WA, Barroso I, Pritchard JK, Gilad Y, et al. (2012) Genomics: ENCODE explained. Nature 489: 52-55.
19. Freedman ML, Monteiro AN, Gayther SA, Coetzee GA, Risch A, et al. (2011) Principles for the post-GWAS functional characterization of cancer risk loci. Nat Genet 43: 513-518.
20. Hardison RC, (2012) Genome-wide Epigenetic Data Facilitate Understanding of Disease Susceptibility Association Studies. J Biol Chem 287: 30932-30940.
21. Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, et al. (2012) Systematic localization of common disease-associated variation in regulatory DNA. Science 337: 1190-1195.
22. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M, (2012) Linking disease associations with regulatory information in the human genome. Genome Res 22: 1748-1759.
23. Cowper-Sal lari R, Zhang X, Wright JB, Bailey SD, Cole MD, et al. (2012) Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nature genetics 44: 1191-1198.
24. Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, et al. (2013) A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nature genetics April 14. doi: 10.1038/ng.2608. [Epub ahead of print].
25. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, et al. (2012) A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Human molecular genetics 21: 5373-5384.
26. Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, et al. (2013) A genome-wide association study of breast cancer in women of African ancestry. Human genetics 132: 39-48.
27. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, et al. (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467: 52-58.
28. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
29. Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H, (2012) FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic acids research 40: e139.
30. Dreszer TR, Karolchik D, Zweig AS, Hinrichs AS, Raney BJ, et al. (2012) The UCSC Genome Browser database: extensions and updates 2011. Nucleic acids research 40: D918-923.
31. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature genetics 39: 311-318.
32. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, et al. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nature genetics 40: 897-903.
33. Song L, Zhang Z, Grasfeder LL, Boyle AP, Giresi PG, et al. (2011) Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome research 21: 1757-1767.
34. Kumar P, Henikoff S, Ng PC, (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature protocols 4: 1073-1081.
35. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. (2010) A method and server for predicting damaging missense mutations. Nature methods 7: 248-249.
36. Brachner A, Braun J, Ghodgaonkar M, Castor D, Zlopasa L, et al. (2012) The endonuclease Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivo. J Cell Sci 125: 1048-1057.
37. Rosenbloom KR, Dreszer TR, Long JC, Malladi VS, Sloan CA, et al. (2012) ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic acids research 40: D912-917.
38. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, et al. (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 42: 880-884.
39. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nature medicine 14: 518-527.
40. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, et al. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer cell 9: 121-132.
41. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC, (2009) Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast cancer research: BCR 11: R7.
42. Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
43. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America 100: 8418-8423.
44. Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, et al. (2005) The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proceedings of the National Academy of Sciences of the United States of America 102: 11005-11010.
45. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
46. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA, (2004) Structure and evolution of transcriptional regulatory networks. Current opinion in structural biology 14: 283-291.
47. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular cell 38: 576-589.
48. Grant CE, Bailey TL, Noble WS, (2011) FIMO: scanning for occurrences of a given motif. Bioinformatics 27: 1017-1018.
49. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, et al. (2006) TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic acids research 34: D108-110.
50. Ward LD, Kellis M, (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic acids research 40: D930-934.
51. Liu Y, Zhong X, Li W, Brattain MG, Banerji SS, (2000) The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells. The Journal of biological chemistry 275: 12231-12236.
52. Seelan RS, Parthasarathy LK, Parthasarathy RN, (2004) E2F1 regulation of the human myo-inositol 1-phosphate synthase (ISYNA1) gene promoter. Archives of biochemistry and biophysics 431: 95-106.
53. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, et al. (2013) Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci. Cell 152: 633-641.
54. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome research 22: 1790-1797.
55. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PloS one 5: e10693.
56. Degner JF, Pai AA, Pique-Regi R, Veyrieras JB, Gaffney DJ, et al. (2012) DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482: 390-394.
57. Myers AJ, Gibbs JR, Webster JA, Rohrer K, Zhao A, et al. (2007) A survey of genetic human cortical gene expression. Nature genetics 39: 1494-1499.
58. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, et al. (2007) Population genomics of human gene expression. Nature genetics 39: 1217-1224.
59. Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, et al. (2008) High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS genetics 4: e1000214.
60. Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, et al. (2010) Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464: 768-772.
61. Montgomery SB, Sammeth M, Gutierrez-Arcelus M, Lach RP, Ingle C, et al. (2010) Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 464: 773-777.
62. Smith AJ, Howard P, Shah S, Eriksson P, Stender S, et al. (2012) Use of allele-specific FAIRE to determine functional regulatory polymorphism using large-scale genotyping arrays. PLoS genetics 8: e1002908.
63. Visvader J, Begley CG, Adams JM, (1991) Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene 6: 187-194.
64. Palii CG, Perez-Iratxeta C, Yao Z, Cao Y, Dai F, et al. (2011) Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages. The EMBO journal 30: 494-509.
65. Hansson A, Manetopoulos C, Jonsson JI, Axelson H, (2003) The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes. Biochemical and biophysical research communications 312: 1073-1081.
66. Ono Y, Fukuhara N, Yoshie O, (1998) TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Molecular and cellular biology 18: 6939-6950.
67. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R, (2010) GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. The Journal of biological chemistry 285: 14042-14051.
68. Kim HW, Ha SH, Lee MN, Huston E, Kim DH, et al. (2010) Cyclic AMP controls mTOR through regulation of the dynamic interaction between Rheb and phosphodiesterase 4D. Molecular and cellular biology 30: 5406-5420.
69. Persani L, Lania A, Alberti L, Romoli R, Mantovani G, et al. (2000) Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas. The Journal of clinical endocrinology and metabolism 85: 2872-2878.
70. Albers M, Kranz H, Kober I, Kaiser C, Klink M, et al. (2005) Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Molecular & cellular proteomics: MCP 4: 205-213.
71. Lemonnier J, Hay E, Delannoy P, Fromigue O, Lomri A, et al. (2001) Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. The American journal of pathology 158: 1833-1842.
72. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, et al. (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129: 3783-3793.
73. Adiseshaiah P, Papaiahgari SR, Vuong H, Kalvakolanu DV, Reddy SP, (2003) Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells. The Journal of biological chemistry 278: 47423-47433.
74. Tapias A, Ciudad CJ, Roninson IB, Noe V, (2008) Regulation of Sp1 by cell cycle related proteins. Cell cycle 7: 2856-2867.
75. Shin S, Verma IM, (2003) BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proceedings of the National Academy of Sciences of the United States of America 100: 7201-7206.
76. Rao MA, Cheng H, Quayle AN, Nishitani H, Nelson CC, et al. (2002) RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. The Journal of biological chemistry 277: 48020-48027.
77. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, et al. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. The Journal of biological chemistry 273: 9158-9167.
78. Qi W, Wu H, Yang L, Boyd DD, Wang Z, (2007) A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. The EMBO journal 26: 65-75.
79. Evert BO, Wullner U, Klockgether T, (2000) Cell death in polyglutamine diseases. Cell and tissue research 301: 189-204.
80. Tarlac V, Storey E, (2003) Role of proteolysis in polyglutamine disorders. Journal of neuroscience research 74: 406-416.
81. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, et al. (2001) Linkage disequilibrium in the human genome. Nature 411: 199-204.
82. Kalhor R, Tjong H, Jayathilaka N, Alber F, Chen L, (2012) Genome architectures revealed by tethered chromosome conformation capture and population-based modeling. Nature biotechnology 30: 90-98.
83. van Berkum NL, Lieberman-Aiden E, Williams L, Imakaev M, Gnirke A, et al. (2010) Hi-C: a method to study the three-dimensional architecture of genomes. Journal of visualized experiments: JoVE 6: 1869.
84. Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, et al. (2012) Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148: 84-98.
85. Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, et al. (2012) In vivo genome editing using a high-efficiency TALEN system. Nature 491: 114-118.
86. Ting MC, Liao CP, Yan C, Jia L, Groshen S, et al. (2012) An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice. Disease models & mechanisms 5: 366-374.
87. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, et al. (2010) Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
88. Volders PJ, Helsens K, Wang X, Menten B, Martens L, et al. (2013) LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic acids research 41: D246-251.
89. Giresi PG, Kim J, McDaniell RM, Iyer VR, Lieb JD, (2007) FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome research 17: 877-885.
90. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
91. Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, et al. (2009) Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS genetics 5: e1000597.
92. Parkhomchuk D, Borodina T, Amstislavskiy V, Banaru M, Hallen L, et al. (2009) Transcriptome analysis by strand-specific sequencing of complementary DNA. Nucleic acids research 37: e123.
93. D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, et al. (2012) Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. PloS one 7: e45684.
94. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. (2013) NCBI GEO: archive for functional genomics data sets-update. Nucleic acids research 41: D991-995.
95. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, et al. (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9: 166-180.